| Financial Year |
March 31 2023 |
| Monetary Funds |
623,931,587.44 |
| Held-for-trading Financial Assets |
140,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
8,319,064.64 |
| Advances to Suppliers |
5,761,064.10 |
| Other Receivables |
8,592.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
39,482,004.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,095,040.82 |
| Total Current Assets |
819,193,613.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
23,172.92 |
| Fixed Assetes |
109,891,230.36 |
| Under-construction Projects |
2,795,394.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,000,334.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
744,996.87 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
142,985,081.17 |
| Total Assets |
962,178,694.98 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
48,526,936.44 |
| Accounts Received In Advance |
1,731,300.00 |
| Employee Compensation Payable |
551,538.09 |
| Taxes Payable |
10,539,264.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
754,871.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
41,743.45 |
| Sub-Total of Current Liabilities |
62,466,757.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,362,386.46 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
449,859.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,238,211.79 |
| Total Liabilities |
72,704,969.26 |
| Paid-In Capital(Or Share Stock) |
160,000,000.00 |
| Capital Surplus |
161,289,034.52 |
| Surplus Reserve |
105,498,507.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
460,136,981.60 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
889,473,725.72 |
| Owner's Equity（Stockholder's Equity） |
889,473,725.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
962,178,694.98 |
